A breast surgeon explains why patients should raise lymphedema with their care team at the start of treatment, and how early detection can make it reversible.
|Videos|March 31, 2016
Bob Dickey on the Value of Relationships From Climbing Mount Kilimanjaro
Author(s)Bob Dickey, Multiple Myeloma Hero
Bob Dickey, a survivor of multiple myeloma, discusses the importance of the relationships formed when he and more than 80 other people climbed Mount Kilimanjaro.
Advertisement
Bob Dickey, a survivor of multiple myeloma, discusses the importance of the relationships formed when he and more than 80 other people climbed Mount Kilimanjaro. The team made the trek as part of the Moving Mountains for Multiple Myeloma effort.
Advertisement
Related to this article
A woman with stage 4 pancreatic cancer shares how a once-daily RAS inhibitor changed her energy, routine and time with family.
Brad Dugai and Russ Reed discuss symptom relief, skin-related side effects and challenges accessing Rasonque, a treatment for pancreatic cancer.
A nurse practitioner discusses how an app provides information on cancer treatments, potential side effects and preparing for medical appointments.
Final KEYNOTE-564 data show Keytruda after kidney cancer surgery lowered the risk of death by 30%. Dr. Toni Choueiri explains what it means for patients.
A physician emphasized how emotional support, reliable health information and caregiver involvement can encourage men to take a more proactive approach to prostate cancer screening and care.
Dr. Hope S. Rugo explains what KEYNOTE-B49 found about adding Keytruda to chemotherapy for PD-L1-positive, HR-positive, HER2-negative breast cancer.
A new trial will test whether a set course of Brukinsa plus sonrotoclax, which target two pathways that drive hairy cell leukemia, can offer an alternative to chemotherapy.
Advertisement
Advertisement
Trending on CURE
1
What Is a Whipple Procedure? Pancreatic Cancer Surgery Explained
2
Pancreatic Cancer and Enzyme Pills: Why They Matter at Every Meal
3
Enhertu Before Surgery Falls Short in HER2-Low Early Breast Cancer
4
Glioblastoma Genomic Testing: What Patients Should Ask
5